Yumetra

Company Overview

Snapshot

Founded in April 2021 by Gilad Agmon and Eli Pinthus, Yumetra operates with 1–10 employees. The company has secured funding across two rounds, including a Pre-Seed round in March 2026 with participation from Fresh Start.

Business overview

Yumetra develops functional food products and plant-derived bioactives aimed at supporting oral health and proactive wellness. The company's core technology is Cinnovir, a patented botanical extract produced through advanced fractionation and formulation. By integrating these bioactives into everyday food formats, Yumetra addresses health at the oral environment without requiring significant changes in consumer behavior, serving markets within the Agriculture & Food Technologies sector.

Strategic signal

In April 2026, Yumetra was featured in a Maariv article highlighting strategic innovation collaborations by the Wingate Institute. This signals growing recognition and potential for partnerships within the Israeli innovation ecosystem, suggesting validation of Yumetra's approach to plant-based bioactives for functional foods.

Company Intelligence Q&A

When was Yumetra founded?

Yumetra was founded in April 2021.

Which investors participated in Yumetra's Pre-Seed funding round?

In March 2026, Yumetra secured Pre-Seed funding with participation from Fresh Start.

Has Yumetra received any grants?

In January 2025, Yumetra received a grant from the Israel Innovation Authority.

What is Yumetra's primary product?

Yumetra's primary products include Cinnovir Functional Candy and Cinnovir Active Ingredient, based on its patented botanical extract.

What is the strategic significance of the Wingate Institute's collaborations mentioned in April 2026?

The Maariv article in April 2026 highlighted Yumetra's involvement in strategic innovation collaborations by the Wingate Institute, indicating the company's integration into broader R&D initiatives and potential for future partnerships in the functional food space.